Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic Review

23 Nov 2022 07:00

RNS Number : 2774H
Applied Graphene Materials PLC
23 November 2022
 

This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").

23 November 2022

Applied Graphene Materials plc

("Applied Graphene Materials", "the Group" or "the Company")

Strategic Review

 

The Company's board of directors has previously outlined its plans to raise further equity in order to fund the Company's operations and the continued development of the business. As announced on 08 November 2022, the Board recently investigated the feasibility of an equity raise with institutional and other investors and concluded that it would not be possible to complete an equity raise successfully at the current time.

 

As announced on 8 November, whilst the Board is pleased with the start that the Company has made to the current financial year, the Company requires additional funding in the near-term in order to continue in operation beyond 31 January 2023.

 

Given the Company's funding position and having regard to the unfavourable conditions in small-cap equity markets, the Board has decided to initiate a strategic review, pursuant to which the Board will consider the options available to maximise value for the Company's shareholders and other stakeholders. Such options could include, but not be limited to, raising additional funding from a specialist debt provider or strategic investor or by realising value from an accelerated sale of the Group's trade and assets or of the shares in the Group's main operating subsidiary. In parallel with the options described above, to seek to protect the financial position of the Company in the event the strategic review does not achieve a satisfactory conclusion, the Board has regrettably decided to commence statutory redundancy consultations with the Company's employees.

 

The Board has appointed Alvarez & Marsal Europe LLP as its financial adviser to manage the strategic review process. Any interested party should contact Alvarez & Marsal at the contact details set out below.

 

The Board will provide further updates to shareholders as appropriate.

 

 

For further information, please contact:

Applied Graphene Materials  +44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

Alvarez & Marsal Europe LLP +44 (0) 784 107 2042

Alex Baird abaird@alvarezandmarsal.com

Singer Capital Markets  (Nominated Adviser and Joint Broker) +44 (0) 207 496 3000

Peter Steel / Amanda Gray

Allenby Capital Limited (Joint Broker) +44 (0) 203 328 5656

Nick Athanas / George Payne (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

Hudson Sandler (Financial PR) +44 (0) 207 796 4133

Nick Lyon / Emily Dillon

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKBBPCBDDFDB
Date   Source Headline
11th Jan 20163:36 pmRNSDirector/PDMR Shareholding
8th Jan 201612:13 pmRNSResult of Meeting
18th Dec 20157:00 amRNSPlacing and Open Offer
16th Nov 20157:00 amRNSFull Year Results
23rd Oct 20157:00 amRNSJoint Development Agreements and Collaborations
21st Sep 20155:19 pmRNSHolding(s) in Company
18th Sep 20157:00 amRNSPeriod end trading update
9th Jul 20157:00 amRNSIssue of share options to Directors
30th Jun 20153:36 pmRNSHolding(s) in Company
17th Jun 20157:00 amRNSFirst Patent Approval
19th May 20154:40 pmRNSSecond Price Monitoring Extn
19th May 20154:35 pmRNSPrice Monitoring Extension
14th May 20157:00 amRNSPositive results from independent oil trials
27th Apr 20159:21 amRNSHolding(s) in Company
22nd Apr 20154:44 pmRNSHolding(s) in Company
22nd Apr 20153:28 pmRNSHolding(s) in Company
21st Apr 20154:46 pmRNSHolding(s) in Company
17th Apr 20157:00 amRNSPositive results from independent coatings trials
2nd Apr 20159:46 amRNSHolding(s) in Company
1st Apr 20154:39 pmRNSHolding(s) in Company
25th Mar 20157:00 amRNSInterim Results
3rd Feb 20157:00 amRNSTrading Update
27th Jan 201511:25 amRNSIssue of equity and total voting rights
22nd Jan 20157:00 amRNSSenior Management Appointments
22nd Dec 20147:00 amRNSDirectorate Change
15th Dec 201411:36 amRNSResult of AGM
15th Dec 20147:00 amRNSAGM Statement
24th Nov 20147:00 amRNSPosting of Annual Report and Notice of AGM
17th Nov 20147:00 amRNSInvestor site visit
5th Nov 20147:00 amRNSAppointment of Non-Executive Director
5th Nov 20147:00 amRNSFull Year Results
5th Sep 20147:00 amRNSPre-close update
28th Jul 20147:00 amRNSIssue of share options to Directors
9th Jul 201410:17 amRNSGrant of Options to Directors
2nd Jul 20144:36 pmRNSHolding(s) in Company
23rd May 20143:08 pmRNSIssue of Share Options
30th Apr 20143:40 pmRNSReplacement - Holding(s) in Company
28th Apr 20148:50 amRNSHolding(s) in Company
1st Apr 20147:00 amRNSAppointment of Non Executive Director
1st Apr 20147:00 amRNSInterim Results
19th Mar 20147:00 amRNSNotice of Interim Results
18th Mar 201411:00 amRNSDirectorate Change
20th Jan 20144:39 pmRNSHolding(s) in Company
15th Jan 201410:59 amRNSIssue of Equity
27th Nov 20134:40 pmRNSSecond Price Monitoring Extn
27th Nov 20134:35 pmRNSPrice Monitoring Extension
26th Nov 20134:40 pmRNSSecond Price Monitoring Extn
26th Nov 20134:35 pmRNSPrice Monitoring Extension
22nd Nov 201312:39 pmRNSHolding(s) in Company
20th Nov 20137:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.